A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.
All of the proceeds will benefit the cancer patients and care teams at the University of Cincinnati Cancer Center. On Tuesday, WLWT was joined by Tasha Stapleton, the vice president of events for ...
Doctors at the University of Cincinnati Cancer Center are exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence. The vaccines are developed from a patient's ...
A new study led by University of Cincinnati Cancer Center researchers details how the accumulation of copper helps clear cell renal cell carcinoma (ccRCC)—the most common kidney cancer—grow ...
Daugherty, MD, lead author of the study and an assistant professor of clinical radiation oncology at the University of Cincinnati Cancer Center said in a statement in 2022. READ ALSO: How are new ...
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.